Special Considerations in the Management of HIV-Infected Patients From Minority Communities

  • Authors: Bisola Ojikutu, MD, MPH; Valerie E. Stone, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/9/18 (What's New)

Summary

  • Blacks and Latinos represent approximately 70% of people with HIV/AIDS in the United States but are approximately 50% less likely to enroll in clinical trials than white patients[Gifford 2002]
  • Contributing Factors
    • Poor access to healthcare, low retention rates, distrust of the healthcare system, lack of knowledge of studies, and not being approached to enroll all contribute to lower participation rates in HIV clinical trials by minorities[Sengupta 2000; Castillo-Mancilla 2014]
    Overcoming Barriers to Participation
    • Improved communication and clinical trial education may encourage greater participation in clinical trials by minorities

Action required